CA2336853A1 — Phenoxyacetic acid derivatives and medicinal compositions containing the same
Assigned to Kissei Pharmaceutical Co Ltd · Expires 2000-01-20 · 26y expired
What this patent protects
The present invention provides novel phenoxyacetic acid derivatives represented by the above general formula and pharmaceutically acceptable salts thereof which have excellent .beta.3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obe…
USPTO Abstract
The present invention provides novel phenoxyacetic acid derivatives represented by the above general formula and pharmaceutically acceptable salts thereof which have excellent .beta.3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of biliary tract. (In the general formula, R1 represents a hydroxy group etc.; one of R2 and R3 is a hydrogen atom, a halogen atom etc., while the other is a hydrogen atom; R4 represents a halogen atom etc.)
Drugs covered by this patent
- Myrbetriq (MIRABEGRON) · Apgdi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.